Pasithea Therapeutics Corp. Quarterly Revenues in USD from Q1 2022 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Pasithea Therapeutics Corp. quarterly/annual Revenues history and growth rate from Q1 2022 to Q4 2022.
  • Pasithea Therapeutics Corp. Revenues for the quarter ending December 31, 2022 was $241K.
  • Pasithea Therapeutics Corp. Revenues for the twelve months ending December 31, 2022 was $487K.
  • Pasithea Therapeutics Corp. annual Revenues for 2022 was $487K, a 3130% increase from 2021.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2022 $487K $241K Oct 1, 2022 Dec 31, 2022 10-K 2023-03-30
Q3 2022 $219K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $13.6K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $13.7K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.